Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Dec 6.

Published in final edited form as: Int J Infect Dis. 2020 Oct 9;101:235–242. doi: 10.1016/j.ijid.2020.09.1452

Table 4.

Concordance between TST and QFT.GIT test in women with valid results

	QFTGIT		Agreement κ value (95%CI)
	QFTGIT+	QFTGIT-	Agreement κ value (95%CI)

All participants (n=317)
TST+	86(27.1%)	19(6.0%)	Agreement=92.7%
TST-	4(1.3%)	208(65.6%)	κ= 0.83
HIV+ Pregnant (n=84)
TST+	17(20.2%)	1(1.2%)	Agreement=97.8%
TST-	0 (0.0%)	66(78.6%)	κ= 0.96
HIV- Pregnant (n=72)
TST+	21(29.2%)	5(6.9%)	Agreement=90.3%
TST-	2(2.8%)	44(61.1%)	κ= 0.78
HIV+ Non-pregnant (n=107)
TST+	25(23.4%)	6(5.6%)	Agreement=94.4%
TST-	0(0.0%)	76(71.0%)	κ= 0.86
HIV- Non-pregnant (n=54)
TST+	23(42.6%)	7(13.0%)	Agreement=83.3%
TST-	2(3.7%)	22(40.7%)	κ= 0.67